Friday, September 30, 2022


Biotechnology News Magazine

Virginia Gambale Is Appointed to Avellino Labs USA BOD

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Virginia Gambale is currently Managing Partner of Azimuth Partners LLC, which is focused on the use of disruptive technologies to assist transforming or facilitating growth in both middle market and large corporations. She has served on more than 20 public and private boards as Chair, Lead Director and Committee Chair roles, including at JetBlue, Motive, Piper Jaffray, Workbrain, Synchronoss Technologies, and IQ Financial.

Virginia Gambale currently serves on several boards, including as Chair of the Board, Director, Chair of Nominating and Corporate Governance, and Audit Committee member at Nutanix; JAMF Audit Committee Member; FD Technologies as their Chair of Nominating and Governance and Audit Committee member; and Virtu Financial as a member of their Audit and Chair of Risk Committee. She is also an Executive Advisor for AttackIQ, a leading cybersecurity optimization platform, and private company director for Banking 10X.

“We are thrilled to welcome Virginia to Avellino. Her expertise in both technology and finance will be invaluable as we continue to leverage the power and promise of genetic science and data technology to support our mission to improve human health,” said Avellino CEO Jon Robson.

“We are in an exceptional time as the scientific community is making novel discoveries on a continual basis, not to mention advances in areas such as AI and machine learning that are accelerating the pace of this scientific knowledge,” said Ms. Gambale. “It is a privilege to join a leading biotechnology firm that is committed to applying the latest scientific and technological knowledge to help improve health and further unlock the mysteries of the human genome. I look forward to applying my skills and expertise toward their mission to advance how we both diagnose and treat disease.”

Ms. Gambale has held significant senior management positions, including as CIO and Managing Director at firms including Merrill Lynch, Bankers Trust, Deutsche Bank and Marsh McLennan. Additionally, she was the Head of Deutsche Bank Strategic Ventures and subsequently a General Partner at Deutsche Bank Capital and ABS Ventures until founding Azimuth Partners in 2003.

A former concert pianist, Ms. Gambale was the Board President of the Newport Music Festival from 2014 to 2019. She is also an adjunct faculty member at Columbia University and Mentor for Columbia University’s Master’s in Technology Leadership program. In addition, she is a frequent lecturer and keynote speaker on the strategic use of emerging technologies and cybersecurity and was one of the first National Association of Corporate Directors (NACD) Fellows.

Virginia Gambale has a B.S. degree in Mathematics and Computer Science from the New York Institute of Technology.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine